Evidence map›Paper›PMID 42501191›Full record

ArticleMedical & biological engineering & computing2026

Prospective motion correction with data reacquisition based on fat navigators for T1-weighted brain MRI at 3T.

Minqiang Jia, Bingbing Zhao, Tuo Yu, Jiayu Zhu, Xijing Zhang, Haohao Peng, Xin Ye, Yichen Zhou, Rongrong Xie, Xinju Zhang and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Medical & biological engineering & computing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Minqiang JiaSchool of Biomedical Engineering & State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai, China.
Bingbing ZhaoSchool of Biomedical Engineering & State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai, China.
Tuo YuSchool of Biomedical Engineering & State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai, China.
Jiayu ZhuUnited Imaging Healthcare, Shanghai, China.
Xijing ZhangUnited Imaging Healthcare, Shanghai, China.
Haohao PengUnited Imaging Healthcare, Shanghai, China.
Xin YeUnited Imaging Healthcare, Shanghai, China.
Yichen ZhouSchool of Biomedical Engineering & State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai, China.
Rongrong XieSchool of Biomedical Engineering & State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai, China.
Xinju ZhangSchool of Biomedical Engineering & State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai, China.
Han ZhangSchool of Biomedical Engineering & State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai, China.
Xiaopeng ZongSchool of Biomedical Engineering & State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai, China. zongxp@shanghaitech.edu.cn.ORCID http://orcid.org/0000-0003-4235-6948

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T1-weighted (T1w) sequence is widely employed in 3T clinical and research MRI. However, its image quality is vulnerable to motion artifacts. We aim to develop a robust prospective motion correction (PMC) method for T1w sequence based on fat navigators (FatNav). Since residual artifacts are often present after PMC, we also evaluated the effectiveness of data reacquisition in reducing such artifacts. Twenty healthy adults and six pediatric participants were scanned with PMC on and off while performing controlled or random head motion. To achieve PMC, the field of view was adjusted in real time based on motion parameters derived from fat navigators. Data acquired between two neighboring navigators that had relative motion score above a certain threshold were reacquired. Image quality was assessed using tissue boundary blurriness, SSIM, PSNR, and cortical and white matter volumes. For images acquired with controlled head movement, PMC with reacquisition significantly increased visual assessment scores from 1.42 ± 0.69 to 3.67 ± 0.76, indicating reduced visible artifacts, and significantly reduced blurriness (p = 0.001) with a mean reduction of 18.6% compared with PMC-off images. In parallel, cortical volume, SSIM, and PSNR significantly increased after PMC (p = 0.012, p = 0.027, and p = 0.043, respectively). Blurriness and cortical volume were fitted against the number of reacquired TRs using a linear model, which suggested an approximately linear trend under the tested conditions. However, the slope of the linear fit was significantly different (p = 0.019 and p = 0.030, respectively) from zero only when the motion scores of the reacquired TR were above a certain threshold. For images acquired with random head motion, visible artifact levels were also reduced with PMC and reacquisition compared to those with PMC off. PMC based on FatNav effectively reduces the impact of motion for T1-weighted MRI at 3 T. Reacquiring data with motion scores above a certain threshold can further improve image quality.

Indexed as

Adipose TissueBrainImage Processing, Computer-AssistedMagnetic Resonance ImagingAdultArtifactsChildFemaleHumansMaleMotionYoung AdultFat navigatorProspective motion correctionSelective reacquisition

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.